The combination of propofol and a rapid-acting opioid, such as fentanyl, sufentanil or remifentanil, is a relatively safe, total intravenous anaesthesia technique, commonly used in humans and which has been investigated in laboratory animals. The objective of this study was to evaluate these combinations for anaesthesia of mice by the intraperitoneal (i.p.) route. Sixty-seven mice, divided into groups of four, were used to test 28 combinations of propofol alone and propofol with fentanyl, sufentanil or remifentanil administered i.p. The dose ranges of drugs studied were propofol 50-200 mg/kg, fentanyl 0.2-0.4 mg/kg, sufentanil 0.05-0.1 mg/kg and remifentanil 0.2-1.0 mg/kg. The loss of righting reflex (RR) and the loss of pedal withdrawal reflex (PWR) were recorded along with the duration and quality of recovery. The results obtained in these studies were unpredictable. The same dose combinations of propofol and opioids were associated with different responses in different individuals. Higher doses did not induce loss of RR and PWR in all animals and were associated with high mortality rates. An adequate hypnotic level was only observed with higher doses of propofol. The synergistic effect of propofol and the opioids was not sufficient to allow surgical procedures. Animals that reached PWR loss showed tail rigidity, shaking limbs and scratched their heads with their forefeet. Higher opioid doses induced respiratory depression and higher death rates. The inconsistency between and within groups may be associated with the i.p. route. The results reported here show that the i.p. route is not appropriate for mouse anaesthesia using propofol alone or in combination with fentanyl, sufentanil or remifentanil.
Anaesthesia protocols for mice are mainly based on combinations of two drugs. The combination of propofol and a fast-acting opioid is a relatively safe and common total intravenous anaesthesia (TIVA) technique used in humans. This combination provides rapid anaesthetic induction, with fast recovery and few side-effects, and has been studied in laboratory animals (Hacker et al. 2005) . Induction and control of anaesthesia with this technique are similar to inhalant anaesthesia, with the advantage of providing perioperative analgesia and no concerns about gas scavenging and operating room pollution (Hacker et al. 2005) . Improvements in anaesthetic management have resulted from the introduction of target-controlled infusion techniques with these drugs (Nunes et al. 2005) .
Propofol (2, 6-diisopropylphenol) is widely used in the clinical setting as an intravenous anaesthetic. Propofol is a short-acting anaesthetic agent that provides rapid, smooth recovery. In mice, it has little analgesic effect compared with morphine (Anwar & Abdel-Rahman 1998) . The necessary analgesia could be obtained through combination with a mu-agonist opioid, such as fentanyl, sufentanil or remifentanil. Fentanyl produces analgesia and sedation in humans. However, these effects are accompanied by muscle rigidity, nausea and respiratory depression. Fentanyl causes excitation and mydriasis when used alone in mice (Gurtu 1990) . Fentanyl, in combination with tranquillizers (droperidol or fluanisone) or sedative/hypnotics (etomidate), produces balanced anaesthesia in mice; combinations of low doses of each component can provide analgesia, unconsciousness and muscle relaxation. The advantages of such an approach is that the undesirable side-effects of some agents can be minimized and often results in more effective anaesthesia with fewer secondary effects on major body systems than when using a single agent (Flecknell & Mitchell 1984 , Flecknell 1996 , Arras et al. 2001 .
Sufentanil and remifentanil are structurally analogous to fentanyl and are used to manage intraoperative pain in humans. Sufentanil has been reported to be 2304 times more potent than morphine in mice (Niemegeers et al. 1976 ). It has a very short and predictable effect. Remifentanil has a very short duration of action with an elimination half-life of less than 10 min in humans, independent of impaired renal or hepatic function (Dershwitz & Rosow 1996 , Hoke et al. 1997 . Pharmacodynamically, remifentanil is similar to the other fentanyl congeners. The drug produces physiological changes consistent with potent mu-receptor agonist activity, including analgesia and sedation. The therapeutic potency of remifentanil is somewhat less than that of fentanyl (Egan 1995) . The synergistic interaction between propofol and shortacting opioids, such as remifentanil, sufentanil or fentanyl, has been investigated in humans and animals. Based on their pharmacological properties, these drugs would appear to be suitable for anaesthesia of small mammals such as mice. However, there are practical limitations associated with the technical difficulties of intravenous administration in mice. In laboratory animals such as rabbits, where veins are easily accessed, drugs such as propofol or thiopental may be administered intravenously, but this process becomes an unreliable technique in conscious uncatheterized mice due to their small size. Alternatively, the anaesthetic drug may be administered by the intraperitoneal (i.p.), intramuscular or subcutaneous route in conscious mice. Other options for anaesthetizing mice include dissociative agents (tiletamine or ketamine) combined with drugs such as benzodiazepines (diazepam or zolazepam) and alpha-2 agonists (xylazine or medetomidine) (Erhardt et al. 1984 , Smith 1993 , Gardner et al. 1995 , Flecknell 1996 , 1997 , Cruz et al. 1998 ). Intraperitoneal injection is easier to perform than intravenous injection; however, it does not allow post-injection adjustment based on effects on the individual animal, so relatively higher doses are often used. This may result in prolonged recovery times in comparison with those associated with intravenous administration (Flecknell 1996) . The successful use of propofol and remifentanil combinations administered by the i.p. route has been described for anaesthesia in rats (Antunes et al. 2003) .
The objective of these studies was to test the i.p. combination of propofol with sufentanil, remifentanil or fentanyl for anaesthesia in mice. Based on evidence reported in studies on humans, we hypothesized that these combinations could provide safe analgesia-anaesthesia protocols, with rapid anaesthetic induction and adequate muscle relaxation.
Materials and methods
All procedures were carried out under personal and project licences approved by the national regulatory office (Direcc -ã o Geral de Veteriná ria [DGV]).
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Animals Sixty-seven locally bred 2-5-month-old male C57BL/6J mice, weighing between 19 and 39 g were used. The animals were kept in a room with controlled temperature (211C) and humidity (55%). Lights were on a 12/ 12 h cycle, with lights off at 17.00 h. Water and rodent pellets (4RF25-GLP Mucedola, SRL; Settimo Milanese, Italy) were provided ad libitum. The animals were reared in Makrolon type II cages, provided with wood shavings litter (Harlan Iberica, S L Barcelona, Spain), tissue nesting material and a cardboard tube. These animals, which had previously been observed in behavioural studies in the same laboratory, were housed in groups of two, three, four, six and seven mice per cage, and two were housed alone.
Drugs
Propofol 2% (Lipuro s , Braun, Melsungen, Germany), fentanyl 0.05 mg/mL (B Braun, Queluz de Baixo, Portugal), sufentanil 5 mg/ mL (Sufenta s , Janssen-Cilag, Queluz de Baixo, Portugal) and remifentanil 20 mg/mL (Ultiva s , GlaxoSmithKline-Produtos Farmacê uticos Lda, Algé s, Portugal) were used in this study. Standard physiological saline 0.9% (Soro Fisioló gico, Paracelcia, Porto, Portugal) was used for dilution.
Experimental procedures
The procedure began with the restraint of the animals. By holding them firmly by the base of the tail, the mice were placed on the lid of the cage. The thumb and index finger of the left hand secured the skin of the neck and lifted the animal while the palm and third finger of the same hand held the tail. The animals were maintained in dorsal recumbence during the administration of drugs. The i.p. injections were performed with the right hand. Intraperitoneal administration was performed lateral to the midline next to the umbilicus. The needle was inserted at an angle of 451 to the abdominal wall in the lower left quadrant of the abdomen with a 15 mm/25 gauge needle. The maximum volume administered was 1.1 mL. Injection and restraint were always performed by the same person. After i.p. injection, animals were placed alone, in separate cages.
Anaesthesia
Each animal received a single administration of propofol alone, or propofol in association with an opioid. The mice were weighed using an electronic scale (EMB 200-1, Kern & Sohn GmbH, Germany) and divided into groups of four for each anaesthetic dose combination. The appropriate drug volumes were calculated and injected i.p. Thirteen animals that received propofol alone in the preliminary study were re-anaesthetized with a propofol-sufentanil combination. The time lapse between successive trials was at least 10 days.
After drug administration, the animal was placed alone in a cage until it lost its righting reflex (RR), and this period of time was recorded. This moment was defined by the lack of ability to return to sternal recumbency. Withdrawal responses were assessed by pinching the tip of the tail and the metacarpal region of the hind foot between the index finger and thumb, and responses were judged as positive or negative. Reflexes were tested every 5 min, alternating between the left and right limbs after the RR was lost. Surgical anaesthesia was defined as complete loss of both tail pinch and pedal withdrawal reflex (PWR) sufficient for performing surgical procedures (Arras et al. 2001) . The animals breathed room air for the duration of the procedure. Their breathing was clinically assessed by evaluating movement of the respiratory muscles and the type of movement observed (thoracic or abdominal) during anaesthesia. Respiratory depression was defined by the inability to use the thoracic muscles; respiratory movements became more abdominal and shallow leading sometimes to apnoea and death. The rectal temperature was monitored and body temperature was maintained between 36 and 381C during anaesthesia using a homeothermic blanket (N-HB101-S-402, Panlab, Spain). At the end of the experiment, the animals that had not lost their RR and those that had recovered Laboratory Animals (2007) 41 their RR were returned to their home cage and were observed for 2 h.
Preliminary study
In a preliminary study, 16 male mice divided into four groups, received doses of 50, 75, 100 and 200 mg/kg of propofol i.p. These data were used to determine an appropriate range of doses for the main study. These animals were later used in the main study.
Main study
The main study was divided into three parts. Three different anaesthetic combinations were utilized and diluted in standard saline solution (0.9%) administered i.p. These combinations were: propofol-remifentanil; propofol-fentanyl and propofol-sufentanil. Table 1 shows the parameters recorded in these studies. Data were calculated with a Microsoft s Excel macro, which also calculated the dose for each mouse. The time intervals were calculated and are shown as mean and standard deviation in minutes.
Data analysis

Results
The results for the different anaesthetic protocols are shown in Table 2 .
Propofol alone
The propofol doses used were generally insufficient to achieve surgical anaesthesia. Results were erratic with all doses, the most predictable combination being the 200 mg/ kg, where three out of four mice lost their RR. The lower dose of propofol (50 mg/kg) failed to induce RR loss and only two mice injected with 75 mg/kg and one with 100 mg/ kg lost their RR. One animal was given propofol at 75 mg/kg but did not recover (Table 2) .
Propofol-fentanyl
Loss of the RR was only observed in some of the mice at each of the propofol-fentanyl combinations. The number of animals that lost their RR increased with higher propofol doses. All animals with 200 mg/kg propofol lost their RR. However, there was no parallel increase in the number of animals losing their PWR. The animals in this group that lost PWR displayed marked respiratory depression, and when this was observed, the animal did not recover from anaesthesia. The period of time between PWR loss and death was short ( Table 2) .
The 100 mg/kg propofol combination induced RR loss in 50% of animals. The most predictable association was the Laboratory Animals (2007) 41
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H C Alves et al. combination of 200/0.2 mg/kg. The propofol-fentanyl combination of 200/ 0.4 mg/kg was less predictable, with highly variable effects on individual mice: two died and the remaining two lost their RR at very different times; 3 and 10 min. One mouse with the 200/0.4 mg/kg dose showed muscle rigidity and spasms before dying. There were some difficulties in differentiating between a positive response to the foot pinch and a muscle spasm. We considered the PWR positive in this animal. (Table 2) .
Propofol-sufentanil
The 50/0.1 mg/kg propofol-sufentanil combination failed to induce RR loss in any animal, resulting only in light sedation. The 100/0.1 and 100/0.05 mg/kg combinations had unpredictable effects regarding the RR loss, and no animal lost its PWR with these doses. PWR loss was only observed with propofol doses of 200 mg/kg. All animals with 200 mg/kg of propofol lost the RR. With a 200/0.05 mg/kg dose, all animals showed PWR loss. However, respiratory depression was observed and only one animal recovered. The interval between PWR loss and death in this group was longer than in the propofol-fentanyl group (Table 2) . Only two of four animals receiving sufentanil 0.1 mg/kg achieved surgical anaesthesia, these animals recovered their PWR but did not recover their RR and died.
Propofol-remifentanil
Within all propofol-remifentanil doses, at least some animals in each group lost their RR, whereas the propofol-remifentanil combinations (50/0.2, 50/0.5 and 75/0.2 mg/ kg) were unpredictable. Higher doses showed a more predictable effect. Table 2 shows times of loss and recovery of the RR. Surgical anaesthesia was never achieved in the 50/0.2 and 50/0.5 groups. In the other Laboratory Animals (2007) 41 Propofol/opioids in mouse anaesthesia 333 Table 2 Number of mice that lost their righting reflex (RR-) and pedal withdrawal reflex (PWR-) with the respective time for induction (T1-T0) and the time for attainment of surgical anaesthesia (T2-T0), death rate with respective superscripted times between loss of PWR and death, time between loss and recovery of the PWR (T3-T2) and the recovery time (T4-T1) of mice when tested with different anaesthetic protocols of propofol and propofol combined with fentanyl, sufentanil and remifentanil Times between loss of PWR and death: a -4 min; b -4 min; c -2.570.7 min; d -20.7713.2 min; e -2678.5 min Ã We considered PWR positive in this animal due to the difficulty in differentiating a positive foot pinch response from spontaneous muscle spasm w These animals died after recovery of PWR. Time data showed in minutes (average7standard deviation) groups, one or two animals reached PWR loss. Respiratory depression, slight tail rigidity, intermittent limb shaking and head scratching with the forefeet were continuously observed during the anaesthesia period. These responses were also present in the other propofol-opioid groups, even though they were observed less frequently. No animals treated with propofol-remifentanil died.
Discussion
Hypothermia and hypoxia have been described as the main causes of anaesthetic death in mice during long anaesthetic recoveries (Green 1979) . The objective of the present study was to develop an anaesthetic combination of propofol and a fast-acting opioid (fentanyl, sufentanil or remifentanil), which would provide a short anaesthetic period with analgesia and a fast recovery without the use of antagonist drugs. The results obtained in these studies were unpredictable. We found that propofolopioid combinations were associated with inconsistent effects between individuals receiving the same doses. Higher doses did not result in the expected predictable induction of surgical anaesthesia and were associated with high mortality rates. In two groups, 75/0.2 mg/kg propofol-remifentanil and 100/0.2 mg/kg propofol-fentanyl, one animal lost its PWR while others did not lose their RR. This was not observed in all other drug combinations; if an animal in a dosage group lost its PWR, all animals in that dose group also lost their RR.
The increase in propofol doses was correlated with a greater number of animals losing the RR, which is in agreement with the reported hypnotic effects of propofol (Kanto 1988) . However, the additive or synergistic effects of propofol and opioids used in these studies were not satisfactory for safe surgical anaesthesia. Propofol administered alone by the i.p. route did not induce an adequate hypnotic level. In the propofol-fentanyl and propofol-sufentanil mice, achievement of surgical anaesthesia was almost always associated with death.
The only animal to survive after loss of PWR was the one that had received the 200/ 0.05 mg/kg propofol-sufentanil combination. On the other hand, combinations with remifentanil showed a higher safety margin compared with other opioids; doses that induced loss of PWR were not associated with death. However at higher remifentanil combinations (1 mg/kg), the volumes required were at the upper limit for i.p administrations in mice. These combinations showed no advantages over the 0.5 mg/kg group and may have caused some distress in the animals. These combinations failed to consistently produce PWR loss, and the quality of surgical anaesthesia was unsatisfactory due to excessive muscle tone and movement. In the three propofol-opioid combinations, tail rigidity, limb shaking and head scratching with the forefeet were observed in some animals after loss of PWR, raising concerns for the wellbeing of the mice. For this reason, doses over 75 mg of propofol were not tested in the remifentanil group. With higher opioid doses, respiratory depression resulting in high death rates was also observed. The animals that lost PWRs with the propofol-fentanyl and propofol-sufentanil combinations often died soon after reaching surgical anaesthesia, thus limiting the study of higher doses.
The inconsistency between and within groups may be associated with the i.p. route. Drugs administered via this route are subject to a high degree of first-pass hepatic metabolism since they are absorbed into the portal system. Another possible explanation for the variability is extraperitoneal or gastrointestinal drug loss (Lewis et al. 1966 , Claassen 1994 , Hedenqvist et al. 2000 . These reasons may contribute to low plasma concentrations with difficulty in reaching and maintaining an adequate propofol effectsite concentration. One further speculation is that respiratory depression of various combinations caused hypoxaemia and hypercarbia severe enough to result in death. This may have been exacerbated by the above-mentioned secondary clinical effects. In a preliminary study in rats using the propofol-remifentanil combination, these secondary effects were not observed, allowing a more stable and safe anaesthesia (Antunes et al. 2003) . Another possibility is that this might be associated with the rat's lower metabolic rate when compared with mice, rats being less sensitive to hypoxaemia and hypercarbia caused by high opioid doses. However, further studies with this species are needed with other opioid combinations to reach any definite conclusion.
These studies were designed with the objective of finding previously untested anaesthesia combinations for mice, with fast induction and recovery, free of side-effects. However, the studied combinations of propofol and mu-agonist opioids showed no advantages in anaesthetic quality and recovery when compared with other protocols for anaesthetizing mice using dissociative drugs (ketamine and tiletamine) with alpha-2 agonists (xylazine and medetomidine) and/or tranquillizers or sedatives (acepromazine, azaperone and zolazepam) (Cruz et al. 1998 , Arras et al. 2001 . The combinations of fentanyl and fluanisone, fentanyl and droperidol, fentanyl and medetomidine or combinations of etomidate and other potent opioids are more reliable for surgical anaesthesia in mice than the combination of propofol and the fastacting opioids used in this study (Flecknell & Mitchell 1984 , Whelan & Flecknell 1994 , Flecknell 1996 .
In conclusion, our results demonstrate the difficulty in finding and proposing an appropriate dose combination for propofol and fentanyl, sufentanil or remifentanil administered by the i.p. route for anaesthesia in mice.
